N status can be evaluated by hypometabolism patterns of [18F]-fluorodeoxyglucose (FDG) PET, atrophy on structural MRI (magnetic resonance imaging), and neurofilament light chain (Nfl) in fluid assays (CSF or plasma). The gene discussed is NEFL; the disease is Atrophy.